MILANOWSKI, Lukasz M, Xu HOU, Jenny M BREDENBERG, Fabienne C FIESEL, Liam T COCKER, Alexandra I SOTO-BEASLEY, Ronald L WALTON, Audrey J STRONGOSKY, Ayman H FAROQI, Maria BARCIKOWSKA, Magdalena BOCZARSKA-JEDYNAK, Jaroslaw DULSKI, Lyuda FEDORYSHYN, Piotr JANIK, Anna POTULSKA-CHROMIK, Katherine KARPINSKY, Anna KRYGOWSKA-WAJS, Tim LYNCH, Diana A OLSZEWSKA, Grzegorz OPALA, Aleksander PULYK, Irena REKTOROVÁ, Yanosh SANOTSKY, Joanna SIUDA, Mariusz WIDLAK, Jaroslaw SLAWEK, Monika RUDZINSKA-BAR, Ryan UITTI, Monika FIGURA, Stanislaw SZLUFIK, Sylwia RZONCA-NIEWCZAS, Elzbieta PODGORSKA, Pamela J MCLEAN, Dariusz KOZIOROWSKI, Owen A ROSS, Dorota HOFFMAN-ZACHARSKA, Wolfdieter SPRINGER a Zbigniew K WSZOLEK. Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2022, roč. 23, č. 13, s. 7086-7097. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms23137086.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Cathepsin B p.Gly284Val Variant in Parkinson's Disease Pathogenesis
Autoři MILANOWSKI, Lukasz M, Xu HOU, Jenny M BREDENBERG, Fabienne C FIESEL, Liam T COCKER, Alexandra I SOTO-BEASLEY, Ronald L WALTON, Audrey J STRONGOSKY, Ayman H FAROQI, Maria BARCIKOWSKA, Magdalena BOCZARSKA-JEDYNAK, Jaroslaw DULSKI, Lyuda FEDORYSHYN, Piotr JANIK, Anna POTULSKA-CHROMIK, Katherine KARPINSKY, Anna KRYGOWSKA-WAJS, Tim LYNCH, Diana A OLSZEWSKA, Grzegorz OPALA, Aleksander PULYK, Irena REKTOROVÁ (203 Česká republika, garant, domácí), Yanosh SANOTSKY, Joanna SIUDA, Mariusz WIDLAK, Jaroslaw SLAWEK, Monika RUDZINSKA-BAR, Ryan UITTI, Monika FIGURA, Stanislaw SZLUFIK, Sylwia RZONCA-NIEWCZAS, Elzbieta PODGORSKA, Pamela J MCLEAN, Dariusz KOZIOROWSKI, Owen A ROSS, Dorota HOFFMAN-ZACHARSKA, Wolfdieter SPRINGER a Zbigniew K WSZOLEK.
Vydání International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2022, 1422-0067.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10608 Biochemistry and molecular biology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.600
Kód RIV RIV/00216224:14740/22:00127440
Organizační jednotka Středoevropský technologický institut
Doi http://dx.doi.org/10.3390/ijms23137086
UT WoS 000824355700001
Klíčová slova anglicky Parkinson's disease; familial forms; monogenic forms; CTSB; fibroblasts
Štítky 14110127, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Pavla Foltynová, Ph.D., učo 106624. Změněno: 3. 4. 2023 10:10.
Anotace
Parkinson's disease (PD) is generally considered a sporadic disorder, but a strong genetic background is often found. The aim of this study was to identify the underlying genetic cause of PD in two affected siblings and to subsequently assess the role of mutations in Cathepsin B (CTSB) in susceptibility to PD. A typical PD family was identified and whole-exome sequencing was performed in two affected siblings. Variants of interest were validated using Sanger sequencing. CTSB p.Gly284Val was genotyped in 2077 PD patients and 615 unrelated healthy controls from the Czech Republic, Ireland, Poland, Ukraine, and the USA. The gene burden analysis was conducted for the CTSB gene in an additional 769 PD probands from Mayo Clinic Florida familial PD cohort. CTSB expression and activity in patient-derived fibroblasts and controls were evaluated by qRT-PCR, western blot, immunocytochemistry, and enzymatic assay. The CTSB p.Gly284Val candidate variant was only identified in affected family members. Functional analysis of CTSB patient-derived fibroblasts under basal conditions did not reveal overt changes in endogenous expression, subcellular localization, or enzymatic activity in the heterozygous carrier of the CTSB variant. The identification of the CTSB p.Gly284Val may support the hypothesis that the CTSB locus harbors variants with differing penetrance that can determine the disease risk.
VytisknoutZobrazeno: 24. 7. 2024 17:30